Recently,a novel radiotracer,[^(18)F]QTFT,synthesized by Li's group1 and published in Acta Pharmaceutica Sinica B,was identified as a PET tracer capable of specifically visualize the anti-inflammatory microglia ta...Recently,a novel radiotracer,[^(18)F]QTFT,synthesized by Li's group1 and published in Acta Pharmaceutica Sinica B,was identified as a PET tracer capable of specifically visualize the anti-inflammatory microglia target P2Y_(12).Compared to other probes,it exhibited high binding affinity and superior blood-brain barrier(BBB)permeability.Moreover,the authors observed increased[^(18)F]QTFT uptake in lesions in neuroinflammation models.展开更多
The blood–brain barrier(BBB) and the blood–brain tumor barrier(BBTB) prevent drug and nano-drug delivery systems from entering the brain. However, ligand-mediated nano-drug delivery systems have significantly enhanc...The blood–brain barrier(BBB) and the blood–brain tumor barrier(BBTB) prevent drug and nano-drug delivery systems from entering the brain. However, ligand-mediated nano-drug delivery systems have significantly enhanced the therapeutic treatment of glioma. In this study we investigated the mechanism especially the integrity of liposomes and lipid disks while traversing the BBB and BBTB both in vitro and in vivo. Fluorophores(DiO, DiI and DiD) were loaded into liposomes and lipid disks to form F?rster resonance energy transfer(FRET) nano-drug delivery systems. Using brain capillary endothelial cells as a BBB model, we show that liposomes and disks are present in the cytoplasm as their intact forms and traverse the BBB with a ratio of 0.68‰ and 1.67‰, respectively. Using human umbilical vein endothelial cells as BBTB model, liposomes and disks remained intact and traversed the BBTB with a ratio of 2.31‰and 8.32‰ at 3 h. Ex vivo imaging and immunohistochemical results revealed that liposomes and disks could traverse the BBB and BBTB in vivo as intact forms. In conclusion, these observations explain in part the mechanism by which nano-drug delivery systems increase the therapeutic treatment of glioma.展开更多
文摘Recently,a novel radiotracer,[^(18)F]QTFT,synthesized by Li's group1 and published in Acta Pharmaceutica Sinica B,was identified as a PET tracer capable of specifically visualize the anti-inflammatory microglia target P2Y_(12).Compared to other probes,it exhibited high binding affinity and superior blood-brain barrier(BBB)permeability.Moreover,the authors observed increased[^(18)F]QTFT uptake in lesions in neuroinflammation models.
基金supported by China Postdoctoral Science Foundation Grant (No.2017M611464)National Basic Research Program of China (973 Program, No. 2013CB932500)+2 种基金National Natural Science Foundation of China (Nos. 81773657, 81690263 and 81473149)Shanghai Education Commission Major Project (2017-01-07-00-07E00052)Shanghai International Science and Technology Cooperation Project (No. 16430723800)
文摘The blood–brain barrier(BBB) and the blood–brain tumor barrier(BBTB) prevent drug and nano-drug delivery systems from entering the brain. However, ligand-mediated nano-drug delivery systems have significantly enhanced the therapeutic treatment of glioma. In this study we investigated the mechanism especially the integrity of liposomes and lipid disks while traversing the BBB and BBTB both in vitro and in vivo. Fluorophores(DiO, DiI and DiD) were loaded into liposomes and lipid disks to form F?rster resonance energy transfer(FRET) nano-drug delivery systems. Using brain capillary endothelial cells as a BBB model, we show that liposomes and disks are present in the cytoplasm as their intact forms and traverse the BBB with a ratio of 0.68‰ and 1.67‰, respectively. Using human umbilical vein endothelial cells as BBTB model, liposomes and disks remained intact and traversed the BBTB with a ratio of 2.31‰and 8.32‰ at 3 h. Ex vivo imaging and immunohistochemical results revealed that liposomes and disks could traverse the BBB and BBTB in vivo as intact forms. In conclusion, these observations explain in part the mechanism by which nano-drug delivery systems increase the therapeutic treatment of glioma.
